Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients

By Kruijf Esther  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 687-696

Springer Publishing Company

Access to resources Recommend Favorite

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

By Dubsky P.   Filipits M.   Jakesz R.   Rudas M.   Singer C. F.   Greil R.   Dietze O.   Luisser I.   Klug E.   Sedivy R.   Bachner M.   Mayr D.   Schmidt M.   Gehrmann M. C.   Petry C.   Weber K. E.   Kronenwett R.   Brase J. C.   Gnant M.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 640-647

Oxford University Press

Access to resources Recommend Favorite

Prognostic Assessment and Adjuvant Treatment Strategies Within Early-Stage, Sporadic Triple Negative Breast Cancer Patients

By Köönigsberg Robert   Pfeiler Georg   Kurzawa Roland   Hudec Marcus   Zeillinger Robert   Dittrich Christian   Singer Christian  

Cancer Investigation, Vol. 29, Iss. 2, 2011-01 ,pp. : 180-186

Informa Healthcare

Access to resources Recommend Favorite

Population-based survival-cure analysis of ER-negative breast cancer

By Huang Lan  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 257-264

Springer Publishing Company

Access to resources Recommend Favorite

Is the Negative Prognostic Value of High Oestrogen Receptor (ER) Levels in Postmenopausal Breast Cancer Patients Due to a Modified ER Gene Product?

By Sancho-Garnier H.   Delarue J.-C.   Mouriesse H.   Contesso G.   May-Levin F.   Gotteland M.   May E.  

European Journal of Cancer, Vol. 31, Iss. 11, 1995-10 ,pp. : 1851-1855

Elsevier

Access to resources Recommend Favorite